Economics at your fingertips  


From Office of Health Economics
Contact information at EDIRC.

Bibliographic data for series maintained by Publications Manager ().

Access Statistics for this working paper series.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.

001922: Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help?
M. Neri and Adrian Towse
001851: Additional Elements of Value for Health Technology Assessment Decisions
S. Karlsberg Schaffer, P. West, Adrian Towse, C. Henshall, J. Mestre-Ferrandiz, R. Masterson and A. Fischer
001842: Incentives for New Drugs to Tackle Anti-Microbial Resistance
J. Ferraro, Adrian Towse and J. Mestre-Ferrandiz
001838: HTA and Decision Making in Asia: How can the available resources be used most effectively to deliver high quality HTA that can be used by health system decision makers?
Adrian Towse and C. Henshall
001837: Transferability of HTA
P. Barnsley, G. Hampson, Adrian Towse and C. Henshall
001836: How can HTA meet the needs of health system and government decision makers?
G. Hampson, Adrian Towse and C. Henshall
001835: Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies
G. Hampson, Adrian Towse and C. Henshall
001741: "New Age" Decision Making in HTA: Is It Applicable in Asia?
Amanda Cole, G. Marsden, N. Devlin, D. Grainger, E.k Lee and W. Oortwijn
001740: How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?
Amanda Cole, A. Chan, M. Mujoomdar, F. Pichler and Adrian Towse
001583: Incentives to follow Best Practice in Health Care
S. Karlsberg Schaffer, J. Sussex and Y. Feng
000492: Developments in Economic Evaluation in Health Care: A Review of HEED
C. Pritchard
000484: Reducing Harm to Patients in the National Health Service. Will the Government's Compensation Proposals Help?
Adrian Towse, P. Fenn, A. Gray, N. Rickman and R. Salinas
000444: Trends in Economic Evaluation
C. Pritchard
000439: GP Commissioning Groups – The Nottingham Experience
S. Earwicker
000438: From Efficacy to Cost-Effectiveness
Adrian Towse and M.f Drummond
000428: The Pros and Cons of Modelling in Economic Evaluation
Office of Health Economics
000427: Regulating Prices Paid by the NHS for Medicines Supplied by the UK-Based Pharmaceutical Industry
M. Cave and Adrian Towse
000424: Health Financing and Pharmaceutical Policy Reform in the Countries of Central and Eastern Europe
F. van Andel
000410: Handling Uncertainty in the Results of Economic Evaluation
A. Briggs
000407: The Impact of Behavioural and Biomedical Advance on Health Trends over the Next 25 Years
M. Hall
000404: Heath Information and the Consumer
J. Griffin
000401: The Impact of Unemployment on Health
J. Griffin
000395: Aids in Africa: Meeting the Challenge through Training Education and Prevention
Office of Health Economics
000385: Factors Influencing Clinical Decisions in General Practice
Office of Health Economics
000383: Economic Evaluation of Growth Hormone Therapy
G. Teeling Smith and R. West
000380: Variations between General Practitioners
R. Robinson and J. Griffin
000379: The Economic Impact of Medicines
G. Teeling Smith
000376: Coronary Heart Disease: The Need for Action
Office of Health Economics
000374: Impact of New Medicines on Heath Care Costs
G. Teeling Smith
000364: HIV and AIDS in the United Kingdom
N. Wells
000363: Health Services in Europe: 1988
G. Teeling Smith
000347: Politics of Prescribing
Office of Health Economics
000335: Keep on Taking the Tablets? A Review of the Problem of Patient Non-Compliance
G. Teeling Snmith
000330: Medicines and the Quality of Life
G. Teeling Smith
000329: Ill in Europe
J. Vaizey
000325: Trends in European Health Spending
Office of Health Economics
000323: Sickness Absence – A Review
N. Wells
000319: Doctors, Nurses and Midwives in the NHS
G. Teeling Smith
000318: Disability in Britain – The Process of Transition
D. Taylor
000316: Accidents in childhood
N. Wells
000315: Mild Hypertension
G. Teeling Smith
000311: End Stage Renal Failure
W. Laing
000310: Effects of Prescription Charges
Office of Health Economics
000302: Perinatal Mortality in Britain – A Question of Class
Office of Health Economics
000300: Immunisation for Everyone – The Polio Experience
Office of Health Economics
000298: Cost of the NHS
Office of Health Economics
000281: Health Care Research Expenditure
Office of Health Economics
000279: Accidents
Office of Health Economics
000278: Viral Hepatitis in Britain
Office of Health Economics
000269: The Faces of Regulation: Profit and Price Regulation of the UK Pharmaceutical Industry after the 1998 Competition Act
J. Mestre-Ferrandiz
000267: Three Challenges to Achieving Better Analysis for Better Decisions: Generalisability, Complexity and Thresholds
Adrian Towse and M. Buxton
000261: Murder, Manslaughter and Infanticide
Office of Health Economics
000253: Infant and Child Health
Office of Health Economics
000252: Accidental deaths
Office of Health Economics
000249: Venereal Diseases
Office of Health Economics
000245: Estimating Pharmaceutical Companies' Value to the Nation: Case Study of the British Pharma Group
M. Garau and J. Sussex
000241: Sixty Years of the NHS: Changes in Demographics, Expenditure, Workforce and Family Services
E. Hawe
000240: Health Care Services and the Single European Market
D. Dawson and L. Mountford
000239: Challenges and Opportunities for Improving Benefit-Risk Assessment of Pharmaceuticals from an Economic Perspective
J.t Cross and L. Garrison
000238: The Market for Biosimilars: Evolution and Policy Options
D. Chauhan, Adrian Towse and J. Mestre-Ferrandiz
000237: New Guidelines for Economic Evaluation in Germany and the United Kingdom: Are We Any Closer to Developing International Standards?
M.f Drummond and F. Rutten
000233: The Impact of Health Technology Assessment on Drug Development
N. Mattison
000232: American Exceptionalism and American Health Care: Implications for the US Debate on Cost-Effectiveness Analysis
P.j Neumann
000231: Deliberative Processes in Decisions about Health Care Technologies
A. Culyer
000230: How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to NHS Patients in England
J. Sussex
000228: Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?
M. Johannesson, B. Jonsson, L. Jonsson, G. Kobelt and N. Zethraeus
000227: Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries
M. Garau and J. Mestre-Ferrandiz
000143: Causes of Death: A Study of a Century of Change in England and Wales
L. Baillie and E. Hawe
000075: What is the Role of HTA for Biosimilars?
J. Mestre-Ferrandiz and Adrian Towse
Page updated 2018-04-24
Sorted by numeric handle